Cited by 223Diabetes, Cardiovascular Risks, and LipoproteinsDiabetes Treatment and ManagementHealth Promotion and Cardiovascular Prevention

The DOI matches its Crossref record; 119 of the 119 references it cites were found in a registry or an index.

9. Cardiovascular Disease and Risk Management

American Diabetes Association·2017·Diabetes Care

DOI 10.2337/dc17-s012

Open this paper in CoChat — free account

Integrity signals

Registry

Crossref · 10.2337/dc17-s012

Cites

119 of 119 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
Zinman, B., Wanner, C., Lachin, J. M., Fitchett, D., Bluhmki, E., Hantel, S., Mattheus, M., Devins, T., Johansen, O. E., Woerle, H. J., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1504720 · Cited by 12,315
Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies
(2002) · The Lancet · doi:10.1016/s0140-6736(02)11911-8 · Cited by 10,266
European Guidelines on cardiovascular disease prevention in clinical practice (version 2012)
Authors/Task Force Members:, Perk, J., De Backer, G., Gohlke, H., Graham, I., Reiner, Ž., Verschuren, M., Albus, C., Benlian, P., Boysen, G., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs092 · Cited by 8,490
2014 Evidence-Based Guideline for the Management of High Blood Pressure in Adults: Report From the Panel Members Appointed to the Eighth Joint National Committee (JNC 8)
James, P. A., Oparil, S., Carter, B. L., Cushman, W. C., Dennison-Himmelfarb, C., Handler, J., Lackland, D. T., LeFevre, M. L., MacKenzie, T. D., Ogedegbe, O., et al. (2014) · JAMA · doi:10.1001/jama.2013.284427 · Cited by 7,950
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
Marso, S. P., Daniels, G. H., Brown-Frandsen, K., Kristensen, P., Mann, J. F. E., Nauck, M. A., Nissen, S. E., Pocock, S., Poulter, N. R., Ravn, L. S., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1603827 · Cited by 7,629
Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy
Brenner, B. M., Cooper, M. E., de Zeeuw, D., Keane, W. F., Mitch, W. E., Parving, H.-H., Remuzzi, G., Snapinn, S. M., Zhang, Z., & Shahinfar, S. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011161 · Cited by 7,493
Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins
(2005) · The Lancet · doi:10.1016/s0140-6736(05)67394-1 · Cited by 6,848
A Randomized Trial of Intensive versus Standard Blood-Pressure Control
The SPRINT Research Group (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1511939 · Cited by 6,325
Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the hypertension optimal treatment (HOT) randomised trial
Hansson, L., Zanchetti, A., Carruthers, S. G., Dahlöf, B., Elmfeldt, D., Julius, S., Ménard, J., Rahn, K. H., Wedel, H., & Westerling, S. (1998) · The Lancet · doi:10.1016/s0140-6736(98)04311-6 · Cited by 5,728
Effects on Blood Pressure of Reduced Dietary Sodium and the Dietary Approaches to Stop Hypertension (DASH) Diet
Sacks, F. M., Svetkey, L. P., Vollmer, W. M., Appel, L. J., Bray, G. A., Harsha, D., Obarzanek, E., Conlin, P. R., Miller, E. R., Simons-Morton, D. G., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200101043440101 · Cited by 5,638

Flagged first, then by citations

Show all 119 references

Research works printed but not linked: 1

American College of Obstetricians and Gynecologists, 2013, Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’ Task Force on Hypertension in Pregnancy, Obstet Gynecol, 122, 1122

Sorted by citations

Items 101–200 of 223

Three-year efficacy and safety of exenatide once weekly: A pooled analysis of three trials
TRAUTMANN, M. E., Gaal, L. V., Han, J., & Hardy, E. (2017) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2017.06.004 · Cited by 13
Risk of cardiovascular event and mortality in relation to refill and guideline adherence to lipid-lowering medications among patients with type 2 diabetes mellitus in Sweden
Karlsson, S. A., Eliasson, B., Franzén, S., Miftaraj, M., Svensson, J., & Sundell, K. A. (2019) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2018-000639 · Cited by 13
Efficacy and safety of dulaglutide 3.0 and 4.5 mg in patients aged younger than 65 and 65 years or older: Post hoc analysis of the AWARD ‐11 trial
Frías, J. P., Bonora, E., Ruiz, L. N., Hsia, S. H., Jung, H., Raha, S., Cox, D. A., Bethel, M. A., & Кониг, М. (2021) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14469 · Cited by 11
Comparative Effectiveness of Bariatric Metabolic Surgery Versus Glucagon-Like Peptide-1 Receptor Agonists on Cardiovascular Outcomes and Mortality: A Meta-Analysis
Saeed, L., Sharif, G., Eda, S., Tullimalli, I. R., Amin, A., Riyalat, A. A., Alrashid, F. F., & Abdelrahim, A. A. (2024) · Cureus · doi:10.7759/cureus.71684 · Cited by 13
Population-Based Strategy for Preventing Diabetes and its Complications
Watanabe, S. (2018) · Diabetes Research - Open Journal · doi:10.17140/droj-4-e011 · Cited by 10
The fasting serum triglyceride levels of elderly population with different progression stages of diabetes mellitus in China
Gao, Y., Man, Q., Jia, S., Li, Y., Li, L., & Zhang, J. (2017) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2017.08.011 · Cited by 10
Fatores Associados a Tensão Arterial Não Controlada em Pessoas com Diabetes Tipo 2 Seguidas nos Cuidados de Saúde Primários em Portugal
Rosendo, I., Santiago, L. M., & Marques, M. (2017) · Acta Médica Portuguesa · doi:10.20344/amp.8321 · Cited by 9
Increasing SBP variability is associated with an increased risk of developing incident diabetic foot ulcers
Brennan, M. B., Guihan, M., Budiman‐Mak, E., Kang, H., Lobo, J. M., Sutherland, B. L., Emanuele, N., Huang, E. S., & Sohn, M. (2018) · Journal of Hypertension · doi:10.1097/hjh.0000000000001783 · Cited by 9
Relationship of Biomarkers of Extracellular Matrix With Myocardial Function In Type 2 Diabetes Mellitus
Liu, J., Chen, Y., Zhen, Z., Ho, L., Tsang, A. M.-C., Yuen, M. M. A., Lam, K. S. L., Tse, H., & Yiu, K. (2017) · Biomarkers in Medicine · doi:10.2217/bmm-2017-0044 · Cited by 9
The long-term effectiveness of metabolic control on cardiovascular disease in patients with diabetes in a real-world health care setting — A prospective diabetes management study
Chen, S., Hou, X., Zhou, X., Yu, J., Xue, H., Hu, G., Sun, Y., Chen, P., Wu, J., Liang, Y., et al. (2019) · Primary care diabetes · doi:10.1016/j.pcd.2019.09.006 · Cited by 7
The prevalence of cardiovascular disease by vascular bed and impact on healthcare costs in a large, real‐world population with type 2 diabetes
Weng, W., Kong, S. X., Ganguly, R., Hersloev, M., Brett, J., Hobbs, T. M., & Baeres, F. M. M. (2020) · Endocrinology Diabetes & Metabolism · doi:10.1002/edm2.106 · Cited by 8
Patterns and preferences of antidiabetic drug use in Turkish patients with type 2 diabetes – A nationwide cross-sectional study (TEMD treatment study)
Haymana, C., Sönmez, A., Demirci, İ., Yaylalı, G. F., Nuhoğlu, İ., Sancak, S., Yılmaz, M., Altuntaş, Y., Dınççağ, N., Sabuncu, T., et al. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108556 · Cited by 9
Evaluation of statin discontinuation stratified by primary versus secondary prevention following bariatric surgery: a retrospective cohort study
Alsuhibani, A. A., Albogami, Y., Diaby, V., Friedman, J. E., & Vouri, S. M. (2021) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2021.01.025 · Cited by 8
Diabetic Foot Ulcer Risk with Diabetic Kidney Disease and Renal Failure among 10,680 Patients
Aziz, K. M. A. (2021) · SciMedicine Journal · doi:10.28991/scimedj-2021-0304-6 · Cited by 8
Healthcare Costs and Resource Utilization Associated with the Use of Empagliflozin Versus Other Antihyperglycemic Agents Among Patients with Type 2 Diabetes Mellitus and Cardiovascular Disease: A Real-World Retrospective Cohort Analysis
Raju, A., Pimple, P. M., Stafkey-Mailey, D., Farrelly, E., & Shetty, S. S. (2021) · Diabetes Therapy · doi:10.1007/s13300-021-01173-0 · Cited by 8
Compliance with Cardiovascular Prevention Guidelines in Type 2 Diabetes Individuals in a Middle-Income Region: A Cross-Sectional Analysis
Barreto, J., Luchiari, B., Wolf, V. L. W., Bonilha, I., Bovi, T. G., Assato, B., Breder, I. S. S., Kimura-Medorima, S. T., Munhoz, D., Quinaglia, T., et al. (2022) · Diagnostics · doi:10.3390/diagnostics12040814 · Cited by 8
Angiotensin-Converting Enzyme Inhibitors vs. Angiotensin Receptor Blockers for the Treatment of Hypertension in Adults With Type 2 Diabetes: Why We Favour Angiotensin Receptor Blockers
Mavrakanas, T. A., & Lipman, M. L. (2017) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2017.11.006 · Cited by 8
Guidelines impact cholesterol management
Yu, S., Zolfaghari, K., Rascati, K. L., Copeland, L. A., Godley, P. J., & McNeal, C. J. (2019) · Journal of clinical lipidology · doi:10.1016/j.jacl.2019.03.002 · Cited by 8
Adherence to the National Guidelines for Follow-Up Protocol in Subjects with Type 2 Diabetes Mellitus in Greece: The GLANCE Study
Papanas, N., Elisaf, M., Kotsa, K., Melidonis, A., Bousboulas, S., Bargiota, A., Pagkalos, E., Doupis, J., Ioannidis, I., Avramidis, I., et al. (2020) · Diabetes Therapy · doi:10.1007/s13300-020-00935-6 · Cited by 9
Glucose metabolism status modifies the relationship between lipoprotein(a) and carotid plaques in individuals with fatty liver disease
Wang, J., Sun, H., Wang, Y., An, Y., Liu, J., & Wang, G. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.947914 · Cited by 9
High risk of renal dysfunction in patients with fulminant type 1 diabetes
Takahashi, N., Tsujimoto, T., Chujo, D., & Kajio, H. (2017) · Journal of Diabetes Investigation · doi:10.1111/jdi.12652 · Cited by 8
Blood pressure management in patients with type 2 diabetes mellitus
Kai, H. (2017) · Hypertension Research · doi:10.1038/hr.2017.55 · Cited by 8
Dapagliflozin/Saxagliptin Fixed-Dose Tablets: A New Sodium-Glucose Cotransporter 2 and Dipeptidyl Peptidase 4 Combination for the Treatment of Type 2 Diabetes
Coppenrath, V. A., & Hydery, T. (2017) · Annals of Pharmacotherapy · doi:10.1177/1060028017731111 · Cited by 8
Physical Activity, Cardiorespiratory Fitness, and the Diabetes Spectrum
Nylén, E., & Kokkinos, P. F. (2019) · Springer eBooks · doi:10.1007/978-3-030-04816-7_11 · Cited by 8
Patterns of Antihypertensive Drug Utilization among US Adults with Diabetes and Comorbid Hypertension: The National Health and Nutrition Examination Survey 1999-2014
Gu, A., Farzadeh, S., Chang, Y. J., Kwong, A., & Lam, S. (2019) · Clinical Medicine Insights Cardiology · doi:10.1177/1179546819839418 · Cited by 8
Real world initiation of newly funded empagliflozin and dulaglutide under special authority for patients with type 2 diabetes in New Zealand
Chepulis, L. M., Rodrigues, M. A., Gan, H., Keenan, R., Kenealy, T. W., Murphy, R., Karu, L. T., Scott‐Jones, J., Clark, P., Moffitt, A., et al. (2025) · BMC Health Services Research · doi:10.1186/s12913-025-12601-3 · Cited by 7
Mediterranean Diet Adherence and Nutritional Status in Dalmatian Diabetic Hypertensive Patients Regarding Presence of Chronic Kidney Disease—Is There Any Difference?
Nenadić, D. B., Radić, J., Kolak, E., Vučković, M., Novak, I., Selak, M., & Radić, M. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19042293 · Cited by 9
Target Blood Pressure and Combination Therapy: Focus on Angiotensin Receptor Blockers Combination with Either Calcium Channel Blockers or Beta Blockers
Farag, S. M., Rabea, H., Abdelrahim, M. E. A., & Mahmoud, H. B. (2022) · Current Hypertension Reviews · doi:10.2174/1573402118666220627120254 · Cited by 7
Longitudinal assessment of the quality of life and patterns of antidiabetic medication use in patients with type 2 diabetes, Saudi Arabia perspective, DISCOVER study
Al-Rubeaan, K. A., Banah, F., Alruwaily, F. G., Sheshah, E., Alnaqeb, D., Al‐Qahtani, A. M., Ewais, D., Juhani, N. A., Hassan, A., & Youssef, A. M. (2022) · Current Medical Research and Opinion · doi:10.1080/03007995.2022.2144052 · Cited by 7
Coronary Artery Disease Screening With Carotid Ultrasound Examination by a Primary Care Physician
Okahara, A., Sadamatsu, K., Matsuura, T., Koga, Y., Mine, D., & Yoshida, K. (2016) · Cardiology Research · doi:10.14740/cr456w · Cited by 9
Frequency of Diet and Physical Activity Goal Attainment and Barriers Encountered Among Adults With Type 2 Diabetes During a Telephone Coaching Intervention
Swoboda, C. M., Miller, C. K., & Wills, C. E. (2017) · Clinical Diabetes · doi:10.2337/cd17-0023 · Cited by 7
Efficacy and Safety of Alirocumab 300 mg Every 4 Weeks in Individuals With Type 2 Diabetes on Maximally Tolerated Statin
Müller‐Wieland, D., Rader, D. J., Moriarty, P. M., Bergeron, J., Langslet, G., Ray, K. K., Manvelian, G. Z., Thompson, D. E., Bujas‐Bobanovic, M., & Roth, E. M. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-02703 · Cited by 7
The effect of ‘paying for performance’ on the management of type 2 diabetes mellitus: a cross-sectional observational study
O'Connor, R., O’Driscoll, R., O’Doherty, J., Hannigan, A., O’Neill, A., Teljeur, C., & O’Regan, A. (2020) · BJGP Open · doi:10.3399/bjgpopen20x101021 · Cited by 7
Tips for management of arrhythmias in endocrine disorders from an European Heart Rhythm Association position paper
Özcan, E. E. (2018) · The Anatolian Journal of Cardiology · doi:10.14744/anatoljcardiol.2018.87260 · Cited by 8
Evolving Role of Non‐Statin Therapy for the Management of Dyslipidemia and Cardiovascular Risk Reduction: Past, Present, and Future
Sisson, E. M., Pamulapati, L. G., Bucheit, J. D., Kelly, M. S., & Dixon, D. L. (2017) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.2074 · Cited by 6
Fimasartan increases glucose‐stimulated insulin secretion in patients with type 2 diabetes and hypertension compared with amlodipine
Yang, Y., Lim, M. H., Lee, S. O., Roh, E., Ahn, C. H., Kwak, S. H., Cho, Y. M., Kim, S., Mari, A., Park, K. S., et al. (2018) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13282 · Cited by 6
Major Adverse Cardiovascular Events Among Obese Patients with Diabetes After Metabolic and Bariatric Surgery: a Meta-analysis of Matched Cohort and Prospective Controlled Studies with 122,361 Participates
Yang, W., Zhan, M., Li, Z. Y., Sun, X., & Zhang, K. (2023) · Obesity Surgery · doi:10.1007/s11695-023-06634-y · Cited by 8
Heartfelt living: Deciphering the link between lifestyle choices and cardiovascular vitality
Jiang, X., Alnoud, M. A. H., Ali, H., Ali, I., Hussain, T., Khan, M. U., Khan, S. U., Khan, M. S., Khan, S. U., Rehman, K. U., et al. (2024) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2024.102397 · Cited by 8
Pharmacological Prevention of Cardiovascular Outcomes in Diabetes Mellitus: Established and Emerging Agents
Saxon, D. R., Rasouli, N., & Eckel, R. H. (2018) · Drugs · doi:10.1007/s40265-017-0857-3 · Cited by 6
Lipids: a personal view of the past decade
Katsiki, N., & Mikhailidis, D. P. (2018) · HORMONES · doi:10.1007/s42000-018-0058-9 · Cited by 6
Purposeful Review to Identify the Benefits, Mechanism of Action and Practical Considerations of Omega-3 Polyunsaturated Fatty Acid Supplementation for the Management of Diabetes Mellitus
Abdissa, D. (2021) · Nutrition and Dietary Supplements · doi:10.2147/nds.s298870 · Cited by 6
Effect of repeatedly applied cold water immersion on subclinical atherosclerosis, inflammation, fat accumulation and lipid profile parameters of volunteers
Tóth, Š., Vachalcová, M., Kaško, D., Turek, M., Guľašová, Z., & Hertelyová, Z. (2023) · Wiener klinische Wochenschrift · doi:10.1007/s00508-023-02246-9 · Cited by 5
Evaluation of a Community-Based Cardiovascular Prevention Program in Patients With Type 2 Diabetes
Finn, Y., Gorecka, M. M., Flaherty, G. T., Dunne, F., O’Brien, T., Crowley, J. J., Wood, D., Connolly, S. B., Jones, J., & Gibson, I. (2020) · American Journal of Health Promotion · doi:10.1177/0890117120931711 · Cited by 5
Impact of a “Pharmacist First” innovative workflow plan in patients with hypertension and/or diabetes
So, R., Hamarneh, Y. N. A., Oleksyn, C., Purschke, M., & Tsuyuki, R. T. (2021) · Canadian Pharmacists Journal / Revue des Pharmaciens du Canada · doi:10.1177/17151635211016498 · Cited by 5
Management of Diabetes Mellitus
Jenkins, A. J., SCOTT, E. S., Fulcher, J., Kilov, G., & Januszewski, A. S. (2018) · Contemporary cardiology · doi:10.1007/978-3-319-97622-8_7 · Cited by 5
Associations of dietary linoleic acid and alpha linolenic acid intake with cardiovascular, cancer and all-cause mortalities in patients with diabetes: NHANES 1999-2008
Jiang, M., Zhu, H., Zhou, X., Zhai, X., Li, S., Ma, W., Liu, K., Cao, J., & Eshak, E. S. (2024) · Frontiers in Clinical Diabetes and Healthcare · doi:10.3389/fcdhc.2024.1318578 · Cited by 5
“Type 2 diabetes mellitus (T2DM) accounts for 90% – 95% of diabetes cases (1).”
BackgroundInfluential
Efficacy and Safety of Atorvastatin 40 mg versus Rosuvastatin 20 mg in Patients with Type 2 Diabetes Mellitus and Previous Acute Coronary Syndrome: A Randomized Clinical Trial
Ebid, A. I. M., Genina, Y. M. F., Al-Jendy, A.-M. A., & El-Sawy, A. M. (2022) · Clinical Diabetology · doi:10.5603/dk.a2022.0021 · Cited by 4
Elevation of small, dense low density lipoprotein cholesterol—a possible antecedent of atherogenic lipoprotein phenotype in type 2 diabetes patients in Jos, North-Central Nigeria
Inaku, K. O., Ogunkeye, O. O., Abbiyesuku, F., Chuhwak, E. K., Isichei, C. O., Imoh, L. C., Amadu, N., & Abu, A. O. (2017) · BMC Clinical Pathology · doi:10.1186/s12907-017-0065-9 · Cited by 4
Manidipine: an antihypertensive drug with positive effects on metabolic parameters and adrenergic tone in patients with diabetes
Saiz-Satjes, M., & Martínez-Martín, F. J. (2018) · Drugs in Context · doi:10.7573/dic.212509 · Cited by 4
More than kin, less than kind: one family and the many faces of diabetes in youth
Franco, L. F., Peixoto-Barbosa, R., Dotto, R. P., Vieira, J. G. H., Dias-da-Silva, M. R., Reis, L. C. F., Giuffrida, F. M. A., & Reis, A. F. (2017) · Archives of Endocrinology and Metabolism · doi:10.1590/2359-3997000000312 · Cited by 4
Longitudinal analysis of atherosclerotic cardiovascular disease risk and healthcare costs in newly diagnosed type 2 diabetes in a real-world setting
Weng, W., Liang, Y. M., Brett, J., Hobbs, T. M., & Baeres, F. M. M. (2019) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2019.107500 · Cited by 4
Variability in the Control of Type 2 Diabetes in Primary Care and Its Association with Hospital Admissions for Vascular Events. The APNA Study
Guillén-Aguinaga, S., Forga, L., Brugos‐Larumbe, A., Guillén‐Grima, F., Guillén-Aguinaga, L., & Aguinaga-Ontoso, I. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10245854 · Cited by 5
Interaction between haptoglobin genotype and glycemic variability on diabetic macroangiopathy: a population-based cross-sectional study
Deng, Z., Wang, S., Lu, J., Zhang, R., Zhang, L. J., Lu, W., Zhu, W., Bao, Y., Zhou, J., & Hu, C. (2023) · Endocrine · doi:10.1007/s12020-023-03484-7 · Cited by 4
Badania typu CVOT (cardiovascular outcomes trials) w cukrzycy typu 2
Cypryk, K., & Małecki, P. (2018) · Endokrynologia Polska · doi:10.5603/ep.2018.0053 · Cited by 4
Effect of Lifestyle Educational Intervention on Blood Pressure in Diabetic Patients with Hypertension
Soheili, S., Pirdehghan, Y., & Hosseini, S.-R. (2020) · Journal of Education and Community Health · doi:10.29252/jech.7.1.59 · Cited by 5
The shifting paradigm in the treatment of type 2 diabetes mellitus—A cardiologist's perspective
Fatima, S., Jameel, A., Ayesha, F., & Menzies, D. J. (2017) · Clinical Cardiology · doi:10.1002/clc.22781 · Cited by 4
Retrospective Comparison of Appropriate Statin Use Between Patients With Diabetes in the Primary Care Setting Managed by Pharmacists or Internal Medicine Providers
Huff, J., Falter, R. A., & Scheinberg, N. (2019) · Diabetes Spectrum · doi:10.2337/ds18-0067 · Cited by 4
Accelerometer-Measured Physical Activity Data Sets (Global Physical Activity Data Set Catalogue) That Include Markers of Cardiometabolic Health: Systematic Scoping Review
Thomas, J. J. C., Daley, A., Esliger, D., Kettle, V. E., Coombe, A., Stamatakis, E. A., & Sanders, J. P. (2023) · Journal of Medical Internet Research · doi:10.2196/45599 · Cited by 3
“As evidence supports the role of both BMI and blood pressure as potential risk factors for cardiovascular disease [147,148], this is not unexpected.”
Modified Lipids as Functional Ingredients for Chronic Disease Management
Amenyenu, E., Abbah, Q. S., Fawole, A. O., & Onuh, J. O. (2025) · Journal of Food Science · doi:10.1111/1750-3841.70526 · Cited by 3
Impact of Endocrine Disorders on Blood Pressure
Carbone, F., Bonaventura, A., Vecchié, A., Casula, M., Liberale, L., Dallegri, F., & Montecucco, F. (2020) · Endocrinology · doi:10.1007/978-3-319-68729-2_2 · Cited by 3
Cardiorespiratory Fitness - New Topics
Sözen, H. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.100928 · Cited by 3
Lipid variability in patients with diabetes mellitus
Lee, J., & Lee, S. (2023) · Cardiovascular Prevention and Pharmacotherapy · doi:10.36011/cpp.2023.5.e18 · Cited by 3
Comparison of optimal cardiovascular risk factor management in patients with Type 2 diabetes who attended urban medical health center with those attended a tertiary care center: Experiences from Tehran, Iran
Moradi, S., Hajighanbari, M. J., & Ebrahimi, H. (2016) · International Journal of Preventive Medicine · doi:10.4103/2008-7802.191440 · Cited by 3
A diabetes mellitus guideline gone wrong — the 2017 ACP update
Home, P. (2017) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2017.9 · Cited by 3
OBJETIVOS TERAPÉUTICOS EN HIPERTENSIÓN ARTERIAL:METAS DE PRESIÓN ARTERIAL EN LOS DIVERSOS SUBGRUPOS DE HIPERTENSOS
Tagle, R., & Mónica Acevedo, B. (2018) · Revista Médica Clínica Las Condes · doi:10.1016/j.rmclc.2017.12.006 · Cited by 2
Optimizing Cardiovascular Outcome in Type 2 Diabetes Mellitus with Better Control of Diabetes Mellitus with Empigliflozin and Hypertension with Renin Angiotensin System Inhibitors and Manidipine Preferably of the Dihydropyridones
Kaur, K. K., Allahbadia, G., & Singh, M. (2020) · Obesity Research - Open Journal · doi:10.17140/oroj-7-141 · Cited by 3
Metformina en enfermedad renal diabética: estado actual
Rodulfo, J. I. A., & Amair, P. (2017) · Revista Colombiana de Nefrología · doi:10.22265/acnef.4.2.255 · Cited by 2
Time for new low density lipoprotein cholesterol (LDL-C) targets?
Daskalopoulou, S. S., & Mikhailidis, D. P. (2017) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2017.1369957 · Cited by 2
Maximum home blood pressure and cardiovascular outcomes in patients with type 2 diabetes: KAMOGAWA-HBP study
Hata, S., Ushigome, E., Yoshimura, T., Takegami, M., Kitagawa, N., Tanaka, T., Hasegawa, G., Ohnishi, M., Tsunoda, S., Yokota, I., et al. (2022) · Journal of Hypertension · doi:10.1097/hjh.0000000000003273 · Cited by 2
State-level metabolic comorbidity prevalence and control among adults age 50-plus with diabetes: estimates from electronic health records and survey data in five states
Mardon, R. E., Campione, J. R., Nooney, J. G., Merrill, L. S., Johnson, M. C., Marker, D. A., Jenkins, F., Saydah, S., Rolka, D. B., Zhang, X., et al. (2022) · Population Health Metrics · doi:10.1186/s12963-022-00298-z · Cited by 3
Diabetes – A Silent Killer: A Threat for Cardiorespiratory Fitness
Joseph, T., & Vadasseril, J. C. (2023) · IntechOpen eBooks · doi:10.5772/intechopen.108164 · Cited by 4
Diabetes prevention in primary care: a review of lifestyle interventions, screening, and risk reduction
Abdullah, M. Y., Esmael, E. A., Alqahtani, K. M., Qahl, K. H., Alanazi, N. A., Alshakhs, H. W., Alayyash, F. A., AlMalki, Y., Alharbi, M., Alharbi, A. I., et al. (2023) · International Journal of Community Medicine and Public Health · doi:10.18203/2394-6040.ijcmph20233551 · Cited by 2
Diabetes in Older Adults
Hudson, M., & Palermo, N. E. (2017) · Springer eBooks · doi:10.1007/978-3-319-20317-1_14-1 · Cited by 2
Blood Pressure–Lowering Targets in Patients With Diabetes Mellitus
Leung, A. A. C., & Padwal, R. S. (2017) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2017.10.024 · Cited by 2
Lowering low-density lipoprotein cholesterol by PCSK9 inhibition in patients with diabetes on insulin therapy: is it efficacious and safe?
Farnier, M. (2018) · Annals of Translational Medicine · doi:10.21037/atm.2018.01.02 · Cited by 2
Correlates of Myopathy in Diabetic Patients Taking Statins
Tariq, S., Goriparthi, L., Ismail, D., Tonpouwo, G. K., Thapa, M., Khalid, K., Cooper, A. C., & Jean-Charles, G. (2023) · Cureus · doi:10.7759/cureus.37708 · Cited by 2
Time in target range for systolic blood pressure and stroke in people with and without diabetes: the Kailuan prospective cohort study
Yang, Y., Wu, S.-L., Zhang, J., Liu, Y., Yin, M., Huo, Z., Chen, S., Wang, G., Xiao, Y., Wang, Y., et al. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1537343 · Cited by 1
Preclinical pharmacology studies of zingerone with special reference to potential therapeutic applications
Singh, B., Singh, H. B., Kaur, S., & Singh, B. (2026) · World Journal of Immunology · doi:10.5411/wji.v16.i1.111511 · Cited by 1
Evaluating the Prescription of Angiotensin-Converting Enzyme Inhibitors or Receptor Blockers in Patients with Diabetes in Jordan
Mayyas, F., Bataineh, W., & Jarab, A. S. (2017) · Endocrine Practice · doi:10.4158/ep171917.or · Cited by 1
Target goal blood pressure in hypertension management
Lee, H. (2017) · Journal of Korean Medical Association · doi:10.5124/jkma.2017.60.10.819 · Cited by 1
SODIUM-GLUCOSE COTRANSPORTER-2 INHIBITORS AS NEW STRATEGY OF CHRONIC HEART FAILURE MANAGEMENT
Herashchenko, A. S., & Fedorov, S. V. (2020) · Emergency Medical Service · doi:10.36740/emems202003109 · Cited by 1
Kardiovaskuläres Risikomanagement bei Typ-2 Diabetes: Werden Menschen mit Typ-2 Diabetes in der diabetologischen Schwerpunktpraxis kardiovaskulär risikoadjustiert behandelt?
Brenner, S., Daikeler, R., Oberaigner, W., & Stummer, H. (2021) · Zeitschrift für Evidenz Fortbildung und Qualität im Gesundheitswesen · doi:10.1016/j.zefq.2021.09.010 · Cited by 1
Macronutrient intake is not associated with cardiovascular risk assessed by Coronary Calcium Score, but dietary fiber showed a significantly inverse relationship
Cunha, N. D. M., Nagano, F. E. Z., de Almeida, C. C. P., Magalhães, T. A., Formentini, F. S., Mezzomo, T. R., Cerci, R., & Júnior, E. L. (2022) · Research Society and Development · doi:10.33448/rsd-v11i10.32721 · Cited by 1
Newer Diabetes Management Options and Physical Fitness to Promote Cardiovascular Benefits
Nylen, E. S. (2022) · Reviews in Cardiovascular Medicine · doi:10.31083/j.rcm2308282 · Cited by 1
Editor’s Pick: Addressing Hypertension in the Patient with Type 2 Diabetes Mellitus: Pathogenesis, Goals, and Therapeutic Approach
Rizvi, A. A. (2017) · EMJ Diabetes · doi:10.33590/emjdiabet/10312697 · Cited by 20
Diabetes Update 2017 – Lipide
Parhofer, K. G. (2017) · Der Diabetologe · doi:10.1007/s11428-017-0233-7 · Cited by 1
Quality of glycemic control in assessment of the requirement for insulin in patients with type 2 diabetes and comorbid pathology
Kurnikova, I., Ualihanova, A. U., Meleshkevich, T. A., & Владимировна, К. Л. (2018) · Diabetes Mellitus · doi:10.14341/dm9601 · Cited by 1
Ten-year atherosclerotic cardiovascular disease risk prediction for postmenopausal women: Impacts of isolated postchallenge hyperglycemia
Wu, T.-H., Lin, Y., & Hwu, C. (2022) · Medicine · doi:10.1097/md.0000000000030352 · Cited by 1
“[15] However, the current ADA’s Standards of Care do not consider using Pooled Cohort Equations for assessing cardiovascular risk in individuals with DM. [16] Instead, the ADA guidelines stratify DM patients by age (<40, 40–75, and >75 years) and ASCVD risk Data are expressed as subject number (%).”
BackgroundResult
Retrospective study on clinical efficacy of Evolocumab in highrisk ASCVD patients
Alzaabi, F. M. M. A., Beshir, S. A., Fattah, E. A., & Gillani, S. W. (2023) · Pharmacy Practice · doi:10.18549/pharmpract.2023.2.2804 · Cited by 1
Patient-centered blood pressure: Thresholds, targets, and tools in diabetes
Kalra, S., Kishor, K., & Gupta, Y. (2017) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/ijem.ijem_37_17 · Cited by 1
Cardiovascular Complications
McCarthy, M. M., & Chyun, D. A. (2017) · American Diabetes Association eBooks · doi:10.2337/9781580405690.ch10 · Cited by 1
Semaglutide improves postprandial glucose and lipid metabolism and delays first-hour gastric emptying in subjects with obesity
Blundell, J. E., Axelsen, M. B., Brooks, A., Flint, A., Kvist, T., Bergan, E. Q., & Hjerpsted, J. (2016) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(16)31220-7
Sodium-glucose cotransporter-2 inhibitors and cardiovascular outcomes in type 2 diabetes mellitus: A systematic review
Nasr, Z. G., Jalali, F., Ahmed, D., & Wilby, K. J. (2017) · Journal of health specialties · doi:10.4103/2468-6360.198800
Letter: Efficacy of Moderate Intensity Statins in the Treatment of Dyslipidemia in Korean Patients with Type 2 Diabetes Mellitus (Diabetes Metab J 2017;41:23-30)
Jeon, J. (2017) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2017.41.2.150
V. Aboyans et al. in response to the article by M. Helfre et al.: Usefulness of a systematic screening of carotid atherosclerosis in asymptomatic people with type 2 diabetes for cardiovascular risk reclassification. Ann Endocrinol (Paris). 2017;78:14–19
Aboyans, V., Désormais, I., Jarlan, L., Teissier, M. P., & Lacroix, P. (2017) · Annales d Endocrinologie · doi:10.1016/j.ando.2017.05.003
Mehr als nur Blutzucker — was für Neurologen und Psychiater wichtig ist
Eschle, D., & Hurni, A. (2017) · DNP - Der Neurologe und Psychiater · doi:10.1007/s15202-017-1823-3
When basal insulin is not enough: successful strategies for insulin intensification in patients with type 2 diabetes mellitus
Biryukova, E. V., Jabbar, A., & Elizarova, S. V. (2017) · Diabetes Mellitus · doi:10.14341/dm8824
Lipidwirksame Therapie bei Diabetes mellitus jenseits von Statinen
Müller‐Wieland, D. (2017) · CardioVasc · doi:10.1007/s15027-017-1274-y
Liraglutide reduced a composite renal outcome at a median 4 y in patients with type 2 diabetes and high CV risk
Lipscombe, L. L. (2017) · Annals of Internal Medicine · doi:10.7326/acpjc-2017-167-12-066
Diabetes mellitus and heart failure: insights from a toxic relationship
Hundertmark, M., & Wicks, E. C. (2018) · Practical Diabetes · doi:10.1002/pdi.2176

Authors: American Diabetes Association
Venue: Diabetes Care
Publisher: American Diabetes Association
Published: 2016-12-12
Volume: 40
Issue: Supplement_1
Pages: S75-S87
ISSN: 0149-5992 (ISSN-L)
1935-5548
DOI: 10.2337/dc17-s012
OpenAlex: W4254397911
Semantic Scholar: ac7f21cc7fc32a6a809a86ed7a1cbf0b7423a650
Cited by: 223
References: 119
Citations by year: 2026: 3 · 2025: 5 · 2024: 7 · 2023: 13 · 2022: 19 · 2021: 16 · 2020: 15 · 2019: 29 · 2018: 47 · 2017: 63 · 2016: 6
FWCI: 7.05
Type: journal article
Language: en
Open access: closed
Licence: www.diabetesjournals.org/content/license (vor, 3 d)
Locations: Diabetes Care (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Health Promotion and Cardiovascular Prevention
Keywords: cardiovascular disease, cardiovascular risk management, diabetes mellitus

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

9. Cardiovascular Disease and Risk Management

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks